Skip to main content
Log in

Recent news from Institute for Clinical and Economic Review

  • News item
  • Published:
PharmacoEconomics & Outcomes News

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Comparative Effectiveness Public Advisory Council

References

  1. Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Publishes Guidance on Improving the Development and Use of Real World Evidence for Drug Coverage and Formulary Decisions. Internet Document : 10 Apr 2018. Available from: URL: https://icer-review.org/announcements/institute-for-clinical-and-economic-review-publishes-guidance-on-improving-the-development-and-use-of-real-world-evidence-for-drug-coverage-and-formulary-decisions/.

  2. Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Releases Draft Evidence Report on CGRP Inhibitors for Migraine Prevention Internet Document : 11 Apr 2018. Available from: URL: https://icer-review.org/announcements/draft-migraine-report/.

  3. Institute for Clinical and Economic Review. Institute for Clinical and Economic Review to Assess Medication-Assisted Therapy for Treatment of Opioid Use Disorder. Internet Document : 5 Apr 2018. Available from: URL: https://icer-review.org/announcements/mat/.

  4. Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Posts Draft Scoping Document on Therapies for Prevention of Hereditary Angioedema Attacks. Internet Document : 12 Apr 2018. Available from: URL: https://icer-review.org/announcements/hae-draft-scope/.

  5. Institute for Clinical and Economic Review. Institute for Clinical and Economic Review's Final Report on Emicizumab Shows New Treatment Improves Health While Lowering Costs for Certain People with Hemophilia A. Internet Document : 16 Apr 2018. Available from: URL: https://icer-review.org/announcements/hemophilia-final-report/.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Recent news from Institute for Clinical and Economic Review. PharmacoEcon Outcomes News 801, 3 (2018). https://doi.org/10.1007/s40274-018-4858-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4858-6

Navigation